Studies related to Acne and Inositol

Efficacy Of Myo-inositol In The Treatment Of Cutaneous Disorders In Young Women With Polycystic Ovary Syndrome

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 50
Sex Female
Age Range 30-44
Body Types Average
Notes for this study:
Supplementation of inositol in young women with PCOS (of which hirstuism and acne are common side effects) was therapeutic over the course of six months of treatment at 2,000mg.

Acne at baseline was either moderate (68%) or severe (32%) and, after supplementation, it was reduced respectively to 34% and 13% with more than half the sample (53%) noting an abolishment of all acne.

No placebo control group was used.